(2023). Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. Bmj Open, 13, e070985. http://doi.org/10.1136/bmjopen-2022-070985
. hypertension
(2023). Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study. Lancet Reg Health Eur, 27, 100604. http://doi.org/10.1016/j.lanepe.2023.100604
. (2023). Ethnic differences in hypertension management, medication use and blood pressure control in UK primary care, 2006-2019: a retrospective cohort study. Lancet Reg Health Eur, 25, 100557. http://doi.org/10.1016/j.lanepe.2022.100557
. (2023). Variation in laboratory testing for patients with long-term conditions: a longitudinal cohort study in UK primary care. Bjgp Open. http://doi.org/10.3399/bjgpo.2022.0139
. (2022). Primary prevention of acute cardiovascular events by influenza vaccination: an observational study. Eur Heart J. http://doi.org/10.1093/eurheartj/ehac737
. (2022). Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study. Bmj Open, 12, e057510. http://doi.org/10.1136/bmjopen-2021-057510
. (2022). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. J Psychopharmacol, 2698811221082470. http://doi.org/10.1177/02698811221082470
. (2022). Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clin Kidney J, 15, 758-770. http://doi.org/10.1093/ckj/sfab225
. (2022). Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink. J Comp Eff Res. http://doi.org/10.2217/cer-2021-0305
.